glp 1 and ketosis Beyond GLP-1 Agonists: An Adaptive Ketogenic–Mediterranean Protocol to Counter Metabolic Adaptation in Obesity Management Added Value to GLP-1 Receptor

It relies on the skin's ability to absorb active compounds and deliver them directly into the bloodstream

Data Availability Statement No new data were created or analyzed in this study

Conclusions According to this multidisciplinary consensus, GLP-1 RAs can be considered easy-to-manage, highly effective medications with a good profile of tolerability to treat people with obesity or T2D

Chronic administration of GLP1 decreased body weight, fat mass, and food intake, whereas no glucoregulatory or insulin-sensitizing actions were detected (Fig

This does not mean everyone with an autoimmune disease should start a GLP-1 medicine

Kamble M, Gupta R, Rehan HS, Gupta LK